Cipla announces termination of stock purchase and merger agreement with Avenue Therapeutics
Cipla announced that the stock purchase and merger agreement entered
between InvaGen Pharmaceuticals Inc. (InvaGen), USA, wholly owned step down subsidiary of the Company, and Avenue Therapeutics Inc (Avenue) has been terminated with effect from 1 November
2021.
However, the 'Stockholders Agreement' dated 12 November 2018 between InvaGen, Avenue and other stockholders remains in force; and InvaGen will continue to hold shares in Avenue.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 13 2022 | 10:08 AM IST